Buscar
Ionis Pharmaceuticals Inc
IONSAñadir a la lista de seguimiento
45.280USD
+1.980+4.57%
Cierre 10-09 16:00（ET）
7.52BCap. mercado
PérdidaP/E TTM
Rendimiento de ingresos de Ionis Pharmaceuticals Inc (IONS)
Actualizado: 31 de dic de 2020Por negocio
Ingresos operativos
Proporción
Anual
Anual
Trimestral
R&D revenue under collaborative agreements
SPINRAZA royalties
Product sales, net
Licensing and other Royalty revenue
FY2020
FY2019
R&D revenue under collaborative agreements
364.56M(49.99%)
770.15M(68.60%)
SPINRAZA royalties
286.58M(39.30%)
292.99M(26.10%)
Product sales, net
70.00M(9.60%)
42.25M(3.76%)
Licensing and other Royalty revenue
8.12M(1.11%)
17.20M(1.53%)